Details for Patent: 9,889,115
Summary for Patent: 9,889,115
| Title: | Fitness assay and associated methods |
| Abstract: | The present invention provides an assay for determining the biochemical fitness of a biochemical species in a mutant replicating biological entity relative to its predecessor. The present invention further provides a continuous fluorogenic assay for measuring the anti-HIV protease activity of protease inhibitor. The present invention also provides a method of administering a therapeutic compound that reduces the chances of the emergence of drug resistance in therapy. |
| Inventor(s): | John W. Erickson, Sergei V. Gulnik, Hiroaki Mitsuya, Arun E. Ghosh |
| Assignee: | University of Illinois System , US Department of Health and Human Services |
| Application Number: | US13/933,319 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 9,889,115
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,889,115
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 500823 | ⤷ Start Trial | |||
| Australia | 4828099 | ⤷ Start Trial | |||
| Australia | 4828199 | ⤷ Start Trial | |||
| Australia | 771780 | ⤷ Start Trial | |||
| Canada | 2336160 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
